Radovich Peter

CIK 00016501313 companiesFOSTER CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001650131

Recent Transactions

50 trades

Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2026-01-22$93.33/sh−2,382→ 20,679 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2026-01-21−4,167→ 8,333 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2026-01-21+4,167→ 23,061 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-03-17$44.21/sh−7,879→ 18,672 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Performance Restricted Stock Units
2025-03-15−14,440→ 7,220 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-03-15+14,440→ 26,551 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-03-04$45.57/sh−13,681→ 13,280 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-03-04$45.74/sh−1,169→ 12,111 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-02-03$48.22/sh−2,627→ 26,961 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-01-24$47.92/sh−3,177→ 29,588 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-01-23+5,750→ 32,765 total
Exercise/Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2025-01-23−5,750→ 11,500 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2025-01-21+12,500→ 12,500 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2025-01-21+50,000→ 50,000 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Performance Restricted Stock Units
2025-01-21+21,660→ 21,660 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2025-01-07$42.82/sh−1,998→ 27,015 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2024-03-25$25.80/sh−4,303→ 29,013 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2024-02-02$26.19/sh−1,790→ 34,695 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−42,596→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−20,000→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−13,890→ 0 total
Disposition to Issuer
Rain Oncology Inc.
Stock Option (Right to Buy)
2024-01-26−35,000→ 0 total
Disposition from Tender
Rain Oncology Inc.
Common Stock, par value $0.001 per share
2024-01-26−8,796→ 0 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2024-01-23+70,000→ 70,000 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Restricted Stock Units
2024-01-23+17,250→ 17,250 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2024-01-08$28.03/sh−1,408→ 36,485 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2023-11-10$22.29/sh+218→ 37,893 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2023-08-09+35,000→ 35,000 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2023-07-03$25.65/sh−1,425→ 37,675 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2023-05-10$16.92/sh+968→ 39,100 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2023-01-31+57,750→ 57,750 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2023-01-31+14,440→ 38,132 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2023-01-09$20.62/sh−1,379→ 33,316 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2022-11-10$17.05/sh+292→ 23,692 total
Award
Rain Oncology Inc.
Stock Option (Right to Buy)
2022-06-01+20,000→ 20,000 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2022-05-10$13.57/sh+1,169→ 23,400 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2022-01-06+60,000→ 60,000 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2022-01-06+10,000→ 22,231 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2021-11-10$13.52/sh+958→ 12,231 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2021-10-01$19.26/sh−1,364→ 11,273 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2021-09-29+8,125→ 12,637 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2021-05-10$14.62/sh+1,006→ 4,512 total
Conversion
Rain Oncology Inc.
Common Stock
2021-04-27+8,796→ 8,796 total
Conversion
Rain Oncology Inc.
Series A Preferred Stock
2021-04-27−9,500→ 0 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2021-01-07+65,000→ 65,000 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2020-11-10$15.27/sh+861→ 3,506 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2020-04-28+185,000→ 185,000 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2018-02-14$62.30/sh−794→ 8,833 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2018-02-14−1,600→ 5,600 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2018-02-14+1,600→ 9,627 total

Companies

Recent Filings

Address

C/O MIRUM PHARMACEUTICALS, INC. 989 E HILLSDALE BLVD., SUITE 300

FOSTER CITY, CA, 94404

View on SEC.gov